Healthcare - Biotechnology - NASDAQ - US
$ 0.023
0 %
$ 532 K
Market Cap
-0.16
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--11.85%
EBIT
Estimate
81.71%
Net Income
Estimate
--3753648.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Peak Bio, Inc.
PKBO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PKBO
EBIT FORECAST
EBIT Forecast Chart PKBO
NET INCOME FORECAST
Net Income Chart PKBO